Quantinuum Inc. Enters $100M CHIPS Award Agreement; Issues 2.37M Shares

What Happened

• Quantinuum announced on Sept. 8, 2026 (with the Award Agreement dated Sept. 4, 2026) that a Quantinuum subsidiary entered into an Other Transaction Agreement with the U.S. Department of Commerce under the CHIPS Act providing up to $100.0 million in funding. In connection with the award, Quantinuum issued 2,369,528 shares of its Class A common stock to the Department of Commerce under a Securities Issuance Agreement dated Sept. 8, 2026.

Key Details

• Award structure: up to $100.0M total, with $56.0M available on or about the award date and additional $32.0M and $12.0M tied to achievement of specified project milestones.
• Project focus: R&D at U.S. sites to scale trapped‑ion quantum computing — including low‑loss integrated photonics at 422 nm, cryogenic high‑voltage ASIC prototyping, and optical component development/packaging.
• IP/data and U.S. nexus: the agreement grants the U.S. government a royalty‑free license to Subject Inventions for government purposes, government‑purpose data rights, restrictions on foreign transfers of award-funded IP for the performance period and at least 10 years thereafter, and requirements to keep production/licensing predominantly in the U.S. for Subject Inventions.
• Remedies and protections: the Department may claw back (as repayable debt) up to the full disbursed award or terminate the award for material noncompliance with research security, domestic IP control, or production requirements. The Company must also file a shelf registration (within ~3 months) to enable resale of the issued shares.

Why It Matters

• Funding and milestones: the award provides a potential non‑dilutive (grant) funding source of up to $100M to support specific quantum R&D, but only $56M is immediately available and the remainder depends on hitting milestones. Investors should watch milestone progress and any draws of the remaining $44M.
• Equity impact and resale: the Company issued 2,369,528 Class A shares to the Department of Commerce and agreed to registration rights (a shelf filing) that could enable resale, so there is potential future share supply to the market.
• Intellectual property and operational constraints: the agreement imposes substantial IP, data, domestic‑production and notification obligations that could affect commercialization, partnerships, or foreign transactions for tech developed under the award. Noncompliance could trigger repayment or termination.
• Next steps for investors: monitor Quantinuum’s disclosures on milestone achievements, shelf registration progress, any material IP or transfer notices, and use of awarded funds to assess dilution, commercialization timing, and program risk.